When Will Xarelto Go Generic? Exploring the 2025 Timeline
Xarelto (rivaroxaban) is a medication used to prevent and treat blood clots. It is a brand-name drug that is currently available only from its manufacturer, Janssen Pharmaceuticals. However, the patent for Xarelto is set to expire in 2025, which means that other companies will be able to produce and sell generic versions of the drug. The availability of… Read More »